6
Oct
2026

Boehringer Ingelheim Biopharmaceuticals

Exhibitor at CPHI Milan 2026 stand 10K57, Contract Manufacturing & Services
About Us

Boehringer Ingelheim BioXcellence™ is the contract manufacturing arm of Boehringer Ingelheim, we have built a reputation as a reliable, world-class partner for biopharmaceuticals manufacturing and global supplies.

With facilities located in the USA, Europe, and Asia, we specialize in mammalian and microbial contract manufacturing, leveraging over 40 years of biotechnology expertise. We offer the full spectrum of services for late-stage products – with a hard-won reputation as a reliable partner accompanying you throughout the lifecycle of your product.

Our track records, both in commercial and clinical supply, speak for themselves - since we started o...

  • Country/Region:
    Germany
  • On CPHI since:
    2023
  • Employees:
    5000+
Company types
CMO/CDMO
Contact info
  • Boehringer Ingelheim Biopharmaceuticals GmbH, Binger Strasse 173, 55216, Ingelheim, Germany
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 10K57, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Downstream Only - Processing for microbial derived proteins

    Product Downstream Only - Processing for microbial derived proteins

    Proven track record in ‘downstream- processing- only’ services Service description: - Intermediate materials, that need to be further purified and/or conjugated - Hormones or other recombinant proteins like virus like particles from inclusion bodies or from biomass - Peptides from inclusion bodies, biom...
  • Early development service for microbial fermentation

    Product Early development service for microbial fermentation

    High throughput process development services for E. coli and yeast based on high degree of automation and digitalization to speed up time to clinic for diverse protein formats e.g., scaffolds, enzymes, pDNA, sub-unit vaccines and antibody fragments. Service description: - Genetic engineering, cell line an...
  • Tech Transfer

    Product Tech Transfer

    Efficient tech transfers from customers or within own global bio-manufacturing network, launch preparation and commercial supply readiness for drug substance and drug product. Service description: - Long-standing track record in product launches - 47 biopharmaceuticals brought to the market - Tailored to...
  • Drug Substance Manufacturing - Mammalian Cell Cultures

    Product Drug Substance Manufacturing - Mammalian Cell Cultures

    • Around 430,000 L total commercial capacity for cell culture  • Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors  • GMP facilities licensed by EMA, FDA, MHLW and other authorities ...
  • Drug Substance Manufacturing - Microbial Fermentation

    Product Drug Substance Manufacturing - Microbial Fermentation

    12,000 L  commercial manufacturing capacity in multi-licensed facility  Two trains  each with 6,000 L of capacity which can be used with flexible scales
    Large-scale GMP facilities licensed by EMA, FDA & MHLW for clinical and commercial global supplies 
    Protein refol...

Boehringer Ingelheim Biopharmaceuticals GmbH Resources (1)